Literature DB >> 6267402

Naloxazone irreversibly inhibits the high affinity binding of [125I]D-ala2-D-leu5-enkephalin.

E Hazum, K J Chang, P Cuatrecasas, G W Pasternak.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6267402     DOI: 10.1016/0024-3205(81)90274-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  7 in total

Review 1.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

2.  Classification of multiple morphine and enkephalin binding sites in the central nervous system.

Authors:  B L Wolozin; G W Pasternak
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

3.  Differential sensitivity of opioid-induced feeding to naloxone and naloxonazine.

Authors:  P E Mann; D Arjune; M T Romero; G W Pasternak; E F Hahn; R J Bodnar
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

4.  Visualization of mu1 opiate receptors in rat brain by using a computerized autoradiographic subtraction technique.

Authors:  R R Goodman; G W Pasternak
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

5.  Oxymorphazone: a long-acting opiate analgesic.

Authors:  G S Ling; S Galetta; G W Pasternak
Journal:  Cell Mol Neurobiol       Date:  1984-03       Impact factor: 5.046

Review 6.  Interactive Mechanisms of Supraspinal Sites of Opioid Analgesic Action: A Festschrift to Dr. Gavril W. Pasternak.

Authors:  Grace C Rossi; Richard J Bodnar
Journal:  Cell Mol Neurobiol       Date:  2020-09-24       Impact factor: 5.046

Review 7.  Exploring Pharmacological Functions of Alternatively Spliced Variants of the Mu Opioid Receptor Gene, Oprm1, via Gene-Targeted Animal Models.

Authors:  Wenjian Kang; Shan Liu; Jin Xu; Anna Abrimian; Ayma F Malik; Raymond Chien; Adejuyigbe Adaralegbe; Akwasi Amponsah; Luca Cartegni; John Pintar; Ying-Xian Pan
Journal:  Int J Mol Sci       Date:  2022-03-10       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.